Detalhe da pesquisa
1.
Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment.
Front Immunol
; 13: 1003975, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36531986
2.
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.
Cancer Res
; 82(20): 3785-3801, 2022 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979635
3.
IL1ß Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D.
Cancer Immunol Res
; 9(3): 309-323, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33361087
4.
Macrophages are metabolically heterogeneous within the tumor microenvironment.
Cell Rep
; 37(13): 110171, 2021 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34965415
5.
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33589525
6.
Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A's: Abundance, Activation and Antigen-Delivery.
Cancers (Basel)
; 11(5)2019 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091774
7.
Stromal-targeting radioimmunotherapy mitigates the progression of therapy-resistant tumors.
J Control Release
; 314: 1-11, 2019 11 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31626860
8.
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
Front Immunol
; 9: 2250, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30349530